Efficiency of the telbivudine administration in the third trimestr of pregnancy for the prevention of perinatal transmission of hepatitis B virus
https://doi.org/10.22625/2072-6732-2015-7-2-105-107
Abstract
Efficiency of the telbivudine administration in the third trimestr of pregnancy for the prevention of perinatal transmission of hepatitis B virus
About the Authors
M. A. Belopolskaya
Clinical Infectious Diseases Hospital named after S.P. Botkin, Saint-Petersburg, Russia
Russian Federation
Russian Federation
S. L. Firsov
Clinical Infectious Diseases Hospital named after S.P. Botkin, Saint-Petersburg, Russia
Russian Federation
Russian Federation
Yu. V. Ostankova
Saint-Petersburg Science Research Institute of Epidemiology and Microbiology named after Pasteur, Saint-Petersburg
Russian Federation
Russian Federation
A. V. Semenov
Saint-Petersburg Science Research Institute of Epidemiology and Microbiology named after Pasteur, Saint-Petersburg
Russian Federation
Russian Federation
O. V. Kalinina
Saint-Petersburg Science Research Institute of Epidemiology and Microbiology named after Pasteur, Saint-Petersburg
North-West Federal Medical Research Centre named after V.A. Almazov, Saint-Petersburg, Russia
Russian Federation
Russian Federation
References
1. World Health Organization: Hepatitis B vaccines. Weekly epidemiological record 2009. 2009, 20-405.
2. Вирусные гепатиты в Российской Федерации. Аналитический обзор. 9 выпуск. Под ред. Покровского В.И., Жебруна А.Б. СПб: ФБУН НИИЭМ имени Пастера. 2013, 168.
3. Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol 2012;12:452–459.
4. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009;190:489–492.
5. Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat 2012;19:e18–e25.
6. Deng M, Zhou X, Gao S et al. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis. Virol J. 2012 Sep 4;9:185.
7. Han GR, Cao MK, Zhao W, et al. A prospective and openlabel study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011, 55: 1215–1221.
Review
For citations:
Belopolskaya M.A., Firsov S.L., Ostankova Yu.V., Semenov A.V., Kalinina O.V. Efficiency of the telbivudine administration in the third trimestr of pregnancy for the prevention of perinatal transmission of hepatitis B virus. Journal Infectology. 2015;7(2):105-107. (In Russ.) https://doi.org/10.22625/2072-6732-2015-7-2-105-107
Views:
542
.png)
.png)
Email this article 